Please login to the form below
Ipsen’s liver cancer treatment clears phase III trial
Cabometyx on track for new liver cancer indication
Sanofi earmarks €170m in new French facility
Will expand its Val de Reuil vaccine production unit
CHMP recommends Teva's generic version of Astellas' Advagraf
Committee backs the drug for transplant rejection prophylaxis
Roche wins CHMP nod for Alecensa licence extensions
Lung cancer monotherapy set for a broader European label
Belgium's Ablynx enters the US market
The biopharma firm's new subsidiary will be led by Daniel Schneider
CETP inhibitor class finally dies as Merck abandons anacetrapib
Cholesterol drug fails to “support regulatory filings”
NICE backs Pfizer’s Xeljanz for RA
But UK’s cost-effectiveness watchdog removes two drugs from CDF
After failing to repeal Obamacare, Trump tries another tack
US president signs executive order encouraging cheaper policies with fewer benefits
Lundbeck and Otsuka start phase III for Rexulti in bipolar
Drug is also in phase II trial to treat PTSD patients
Moving times
Continuity and stability are vital when it comes to the EMA's relocation when it leaves London
-
Signal strengthCommunications that connect
-
Forming a picture of healthAs life expectancy increases how can stakeholders ensure the last decades of life are healthy ones?
-
Pfizer could raise ‘up to $15bn’ from consumer unit saleWould follow in the footsteps of Novartis, Boehringer and Merck & Co if it does strike a deal
-
SMC backtracks on Janssen’s multiple myeloma treatment DarzalexWill now recommend the first-in-class treatment after securing a discount
-
Prospects for Lilly’s Verzenio hit by botched lung cancer trialThe CDK 4/6 inhibitor failed to improve overall survival in a late-stage study
-
Merck earmarks €35m for Italian biologics site developmentPharma firm plans new biotech production line at its Bari facility
-
HCA looks for mental health 'champions' in healthcare communications
Marks World Mental Health day with community group partnership
-
Freedom of movement 'unlocks' scientific successNature study finds mobility gave researchers higher citation rates than those who remained in their homeland
-
AZ starts pursuit of lung cancer indication for ImfinziAnd its EGFR inhibitor Tagrisso picks up US breakthrough status
Latest appointments
-
Smith & Nephew’s Oliver Bohuon plans his departureHe will step down as CEO by the end of 2018 to retire
-
Lighthouse Medical Communications appoints Andy Willmer as managing directorHe will lead the Lucid Group's US company
-
Cellectis’ Mathieu Simon will serve as interim chief medical officerHe will take over the responsibilities of Loan Hoang-Sayag
-
Bayer UK and Ireland appoints new CEOLars Bruening succeeds Alex Moscho
-
Sanofi appoints Stefan Oelrich to its executive teamHe joins as executive vice president, diabetes and cardiovascular
Featured jobs
- Scientific Director, Medical Communications
-
£60 – 70, 000 benefits
-
Medical Editor
-
Great salary and benefits
-
Principal Medical Writer
-
Great salary and benefits
- Account Director, Healthcare Communications
-
£50, 000 - £60, 000
- Scientific Team Leader, Medical Education
-
£55, 000 – £70, 000 benefits
-
Account Director
-
Salary TBC
-
Editorial Director - BioScience
-
Competitive Salary
-
Account Director at PAREXEL MedCom
-
Competitive Salary
- Digital Account Director – Healthcare Communications
-
£50 – 60, 000 benefits
Subscribe to our email news alerts
- Roche and J&J picked for ‘revolutionary’ digital health pilot
- J&J files would-be prostate cancer blockbuster in US
- Pfizer could raise ‘up to $15bn’ from consumer unit sale
- Xarelto no better than aspirin in secondary stroke study
- Lilly strengthens team with in-house promotions
- NICE backs Pfizer’s Xeljanz for RA
- Ipsen’s liver cancer treatment clears phase III trial
- Sanofi earmarks €170m in new French facility
- Smith & Nephew’s Oliver Bohuon plans his departure
- Multichannel in pharma
- Lighthouse Medical Communications appoints Andy Willmer as managing director
- Harnessing the power of core elements to optimise market access
PMHub
Four Health Communications
Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...
Latest intelligence
- Harnessing the power of core elements to optimise market access
- This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
- So how do you really engage with patients?
- The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
- Avoiding data pitfalls in clinical research
- Genomics sequencing and sensors will present new challenges...
Quick links
Infographics
